I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 19% ± 3% | |
| goblet cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 19% ± 3% | |
| goblet cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of SLC35C1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3185.15 | 1444 / 1445 | 100% | 50.51 | 183 / 183 |
| intestine | 100% | 2273.78 | 965 / 966 | 100% | 64.84 | 527 / 527 |
| pancreas | 100% | 1373.35 | 327 / 328 | 100% | 52.78 | 178 / 178 |
| liver | 100% | 8541.37 | 226 / 226 | 100% | 75.85 | 404 / 406 |
| uterus | 100% | 1376.24 | 170 / 170 | 99% | 35.22 | 455 / 459 |
| bladder | 100% | 2190.76 | 21 / 21 | 99% | 45.34 | 499 / 504 |
| prostate | 100% | 1912.25 | 245 / 245 | 99% | 28.56 | 497 / 502 |
| stomach | 99% | 1609.36 | 356 / 359 | 100% | 58.19 | 285 / 286 |
| breast | 100% | 3268.90 | 459 / 459 | 98% | 30.38 | 1100 / 1118 |
| ovary | 98% | 1096.77 | 177 / 180 | 100% | 34.74 | 429 / 430 |
| thymus | 100% | 1307.42 | 650 / 653 | 99% | 23.94 | 596 / 605 |
| skin | 98% | 1538.25 | 1767 / 1809 | 99% | 35.07 | 468 / 472 |
| kidney | 98% | 1220.13 | 87 / 89 | 98% | 22.63 | 879 / 901 |
| lung | 96% | 1733.38 | 552 / 578 | 100% | 41.99 | 1150 / 1155 |
| adrenal gland | 100% | 1245.01 | 257 / 258 | 90% | 17.14 | 208 / 230 |
| brain | 89% | 682.22 | 2356 / 2642 | 100% | 20.46 | 703 / 705 |
| adipose | 100% | 4195.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 25.74 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 21.74 | 29 / 29 |
| spleen | 100% | 1543.64 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 29.85 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.64 | 1 / 1 |
| blood vessel | 100% | 1316.53 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 914.75 | 832 / 861 | 0% | 0 | 0 / 0 |
| muscle | 84% | 653.48 | 673 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 78% | 834.43 | 726 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0036085 | Biological process | GDP-fucose import into Golgi lumen |
| GO_0030259 | Biological process | lipid glycosylation |
| GO_0045746 | Biological process | negative regulation of Notch signaling pathway |
| GO_0036066 | Biological process | protein O-linked fucosylation |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0015297 | Molecular function | antiporter activity |
| GO_0005457 | Molecular function | GDP-fucose transmembrane transporter activity |
| Gene name | SLC35C1 |
| Protein name | Solute carrier family 35 member C1 GDP-fucose transporter 1 (Solute carrier family 35 member C1) GDP-fucose transporter 1 Solute carrier family 35, member C1, isoform CRA_b (cDNA FLJ33926 fis, clone CTONG2017409, highly similar to GDP-fucose transporter 1) (cDNA FLJ90448 fis, clone NT2RP3001271, highly similar to GDP-fucose transporter 1) |
| Synonyms | FUCT1 hCG_1785265 |
| Description | FUNCTION: Antiporter specific for GDP-l-fucose and depending on the concomitant reverse transport of GMP. Involved in GDP-fucose import from the cytoplasm into the Golgi lumen. . |
| Accessions | ENST00000526817.1 ENST00000442528.2 [Q96A29-2] ENST00000526817.2 [Q96A29-2] E9PS26 E9PPI4 ENST00000314134.4 [Q96A29-1] B3KQH0 Q96A29 ENST00000530471.1 |
